BG
CRL icon

BlackRock Group’s Charles River Laboratories CRL Stock Holding History

BlackRock Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.1M Buy
53,775
+4,230
+9% +$321K ﹤0.01% 1299
2016
Q3 		$4.13M Sell
49,545
-7,189
-13% -$603K ﹤0.01% 1201
2016
Q2 		$4.67M Sell
56,734
-2,304
-4% -$190K ﹤0.01% 1121
2016
Q1 		$4.48M Sell
59,038
-254,902
-81% -$18.9M ﹤0.01% 1123
2015
Q4 		$25.2M Sell
313,940
-398,739
-56% -$28.8M 0.01% 732
2015
Q3 		$45.3M Buy
712,679
+5,680
+0.8% +$408K 0.03% 595
2015
Q2 		$49.7M Buy
706,999
+62,556
+10% +$4.63M 0.03% 601
2015
Q1 		$51.1M Buy
644,443
+81,496
+14% +$6.01M 0.03% 587
2014
Q4 		$35.8M Buy
562,947
+67,111
+14% +$4.21M 0.02% 667
2014
Q3 		$29.6M Buy
495,836
+77,650
+19% +$4.44M 0.02% 696
2014
Q2 		$22.4M Sell
418,186
-12,939
-3% -$710K 0.01% 761
2014
Q1 		$26M Buy
431,125
+402,931
+1,429% +$23.5M 0.02% 709
2013
Q4 		$1.5M Sell
28,194
-311
-1% -$15.6K ﹤0.01% 1734
2013
Q3 		$1.32M Buy
28,505
+2,158
+8% +$99K ﹤0.01% 1734
2013
Q2 		$1.08M Buy
+26,347
New +$1.13M ﹤0.01% 1694

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Group's CRL Position: Q4 2016 in Review

BlackRock Group increased its Charles River Laboratories (CRL) stake by 8.5% in Q4 2016, buying an estimated $321K and bringing the position to 53,775 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

BlackRock Group first reported a position in CRL in Q2 2013 and has held it in 15 quarters since. The position peaked at $51.1M in Q1 2015. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • BlackRock Group held 53,775 shares of Charles River Laboratories worth $4.1M as of Q4 2016.
  • BlackRock Group bought 4,230 Charles River Laboratories shares in Q4 2016, an estimated $321K.
  • Charles River Laboratories made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1299 holding.
  • BlackRock Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Charles River Laboratories position peaked at $51.1M in Q1 2015.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.